Physician profile
Daniel P Elskens
NPI 1477661114
$74,613.32
in general payments reported to CMS, 2019-2025
10 companies · $10K in 2025
The $10K reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $10K · 2022: $10K · 2023: $10K · 2024: $10K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $30K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $30,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $60,125.00 | 2019-2024 | Ravine Lateral Access System |
| Vb Spine LLC | $10,000.00 | 2025 | Canyon Retractor Systems |
| Globus Medical, INC. | $2,098.76 | 2019 | |
| Nuvasive, INC. | $832.97 | 2019-2022 | |
| Medtronic USA, INC. | $612.55 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $386.25 | 2019-2020 | |
| Orthofix Medical, INC. | $288.96 | 2019-2021 | |
| Nevro Corp. | $133.79 | 2021 | |
| Medtronic, INC. | $119.55 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Elskens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.